ZBH · 8-K · 20260805PR335108
Product Category Demand Trends
ZIMMER BIOMET HOLDINGS, INC. · 2026-08-05 · Importance 54 · Surprise 40 · In source text
Zimmer Biomet’s 2025 net sales by product category were $3,322.3 million for Knees, $2,093.5 million for Hips, $2,150.2 million for Sports Medicine, Extremities and Trauma (S.E.T.), and $665.6 million for Technology & Data, Bone Cement and Surgical. S.E.T. sales increased to $2,150.2 million from $1,865.7 million in 2024, a roughly 15% year-over-year increase and the strongest growth among the disclosed categories. Knee sales rose from $3,173.5 million to $3,322.3 million, while Hip sales rose from $1,999.1 million to $2,093.5 million.
Key facts
- S.E.T. net sales increased 15.2 percent in 2025; Paragon 28 had a positive effect of 10.5 percent on S.E.T. net sales and foreign currency contributed 0.6 percent. source
- Within S.E.T., net sales growth by subcategory: CMFT 12.5 percent, upper extremities 8.2 percent, sports medicine 5.5 percent; biologics declined 14.2 percent and trauma declined 0.7 percent. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | realized | — | S.E.T. net sales increased 15.2 percent in 2025; Paragon 28 had a positive effect of 10.5 percent on S.E.T. net sales and foreign currency… |